Hyperthermia enhances bortezomib-induced apoptosis in human white blood cancer cells

Dinara Baiskhanova, Timur Saliev, Dinara Begimbetova, Loreto B. Feril, Anton Klodzinskyi, Katsuro Tachibana, Xeniya Merinyanu

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

At present, the current therapeutic strategy for apoptosis induction mainly relies on the administration of
pharmacological apoptotic modulators. Apart from that, apoptosis can be induced by various external stimuli
such as hyperthermia, ionizing radiation, and electric fields. Despite advantages, both physical and pharmacological
approaches bear some limitations as well. The rationale of this study was to overcome the limitations
by combining hyperthermia and apoptotic modulator ‘bortezomib’ (Velcade). Two types of human blood cancer
cell lines were utilized: human leukemic monocyte lymphoma cell U937 line and peripheral blood mononuclear
cells (PMBCs) derived from the patient diagnosed with acute myeloid leukemia. Prior to apoptosis experiments,
cytotoxicity tests were performed at three types of temperature regimes (40 °, 42 ° and 44 °C). We observed a
gradual inhibition of cell viability correlating with an increase of temperature and drug concentration in both
cell lines. However, there was no significant difference between sham group and groups of leukemic PMBCs
treated by high temperature (44 °C) and bortezomib. In U937 cells, combined treatment by heat shock and
bortezomib led to an increase the number of cells underwent the late apoptosis stage. At the same time, similar
treatment of PMBCs resulted in the stimulation of early apoptosis. Our data suggest that combination of
bortezomib and hyperthermia enhances apoptosis induction in human cancer white blood cells, indicating a
therapeutic potential for blood cancer therapy.
Original languageEnglish
Pages (from-to)9-14
Number of pages6
JournalJournal of Thermal Biology
Publication statusPublished - 2017

Fingerprint

blood cells
fever
Leukocytes
Blood
Fever
apoptosis
Cells
Apoptosis
Neoplasms
Modulators
Temperature
blood
myeloid leukemia
therapeutics
U937 Cells
temperature
neoplasms
Ionizing radiation
electric field
Cytotoxicity

Keywords

  • Hyperthermia, cytotoxicity, apoptosis, bortezomib, velcade, blood cancer

Cite this

Baiskhanova, D., Saliev, T., Begimbetova, D., Feril, L. B., Klodzinskyi, A., Tachibana, K., & Merinyanu, X. (2017). Hyperthermia enhances bortezomib-induced apoptosis in human white blood cancer cells. Journal of Thermal Biology, 9-14.

Hyperthermia enhances bortezomib-induced apoptosis in human white blood cancer cells. / Baiskhanova, Dinara; Saliev, Timur; Begimbetova, Dinara; Feril, Loreto B.; Klodzinskyi, Anton ; Tachibana, Katsuro; Merinyanu, Xeniya.

In: Journal of Thermal Biology, 2017, p. 9-14.

Research output: Contribution to journalArticle

Baiskhanova, D, Saliev, T, Begimbetova, D, Feril, LB, Klodzinskyi, A, Tachibana, K & Merinyanu, X 2017, 'Hyperthermia enhances bortezomib-induced apoptosis in human white blood cancer cells', Journal of Thermal Biology, pp. 9-14.
Baiskhanova, Dinara ; Saliev, Timur ; Begimbetova, Dinara ; Feril, Loreto B. ; Klodzinskyi, Anton ; Tachibana, Katsuro ; Merinyanu, Xeniya. / Hyperthermia enhances bortezomib-induced apoptosis in human white blood cancer cells. In: Journal of Thermal Biology. 2017 ; pp. 9-14.
@article{58ec33efd00844d9a3c2117e3179cc1d,
title = "Hyperthermia enhances bortezomib-induced apoptosis in human white blood cancer cells",
abstract = "At present, the current therapeutic strategy for apoptosis induction mainly relies on the administration ofpharmacological apoptotic modulators. Apart from that, apoptosis can be induced by various external stimulisuch as hyperthermia, ionizing radiation, and electric fields. Despite advantages, both physical and pharmacologicalapproaches bear some limitations as well. The rationale of this study was to overcome the limitationsby combining hyperthermia and apoptotic modulator ‘bortezomib’ (Velcade). Two types of human blood cancercell lines were utilized: human leukemic monocyte lymphoma cell U937 line and peripheral blood mononuclearcells (PMBCs) derived from the patient diagnosed with acute myeloid leukemia. Prior to apoptosis experiments,cytotoxicity tests were performed at three types of temperature regimes (40 °, 42 ° and 44 °C). We observed agradual inhibition of cell viability correlating with an increase of temperature and drug concentration in bothcell lines. However, there was no significant difference between sham group and groups of leukemic PMBCstreated by high temperature (44 °C) and bortezomib. In U937 cells, combined treatment by heat shock andbortezomib led to an increase the number of cells underwent the late apoptosis stage. At the same time, similartreatment of PMBCs resulted in the stimulation of early apoptosis. Our data suggest that combination ofbortezomib and hyperthermia enhances apoptosis induction in human cancer white blood cells, indicating atherapeutic potential for blood cancer therapy.",
keywords = "Hyperthermia, cytotoxicity, apoptosis, bortezomib, velcade, blood cancer",
author = "Dinara Baiskhanova and Timur Saliev and Dinara Begimbetova and Feril, {Loreto B.} and Anton Klodzinskyi and Katsuro Tachibana and Xeniya Merinyanu",
year = "2017",
language = "English",
pages = "9--14",
journal = "Journal of Thermal Biology",
issn = "0306-4565",
publisher = "Elsevier",

}

TY - JOUR

T1 - Hyperthermia enhances bortezomib-induced apoptosis in human white blood cancer cells

AU - Baiskhanova, Dinara

AU - Saliev, Timur

AU - Begimbetova, Dinara

AU - Feril, Loreto B.

AU - Klodzinskyi, Anton

AU - Tachibana, Katsuro

AU - Merinyanu, Xeniya

PY - 2017

Y1 - 2017

N2 - At present, the current therapeutic strategy for apoptosis induction mainly relies on the administration ofpharmacological apoptotic modulators. Apart from that, apoptosis can be induced by various external stimulisuch as hyperthermia, ionizing radiation, and electric fields. Despite advantages, both physical and pharmacologicalapproaches bear some limitations as well. The rationale of this study was to overcome the limitationsby combining hyperthermia and apoptotic modulator ‘bortezomib’ (Velcade). Two types of human blood cancercell lines were utilized: human leukemic monocyte lymphoma cell U937 line and peripheral blood mononuclearcells (PMBCs) derived from the patient diagnosed with acute myeloid leukemia. Prior to apoptosis experiments,cytotoxicity tests were performed at three types of temperature regimes (40 °, 42 ° and 44 °C). We observed agradual inhibition of cell viability correlating with an increase of temperature and drug concentration in bothcell lines. However, there was no significant difference between sham group and groups of leukemic PMBCstreated by high temperature (44 °C) and bortezomib. In U937 cells, combined treatment by heat shock andbortezomib led to an increase the number of cells underwent the late apoptosis stage. At the same time, similartreatment of PMBCs resulted in the stimulation of early apoptosis. Our data suggest that combination ofbortezomib and hyperthermia enhances apoptosis induction in human cancer white blood cells, indicating atherapeutic potential for blood cancer therapy.

AB - At present, the current therapeutic strategy for apoptosis induction mainly relies on the administration ofpharmacological apoptotic modulators. Apart from that, apoptosis can be induced by various external stimulisuch as hyperthermia, ionizing radiation, and electric fields. Despite advantages, both physical and pharmacologicalapproaches bear some limitations as well. The rationale of this study was to overcome the limitationsby combining hyperthermia and apoptotic modulator ‘bortezomib’ (Velcade). Two types of human blood cancercell lines were utilized: human leukemic monocyte lymphoma cell U937 line and peripheral blood mononuclearcells (PMBCs) derived from the patient diagnosed with acute myeloid leukemia. Prior to apoptosis experiments,cytotoxicity tests were performed at three types of temperature regimes (40 °, 42 ° and 44 °C). We observed agradual inhibition of cell viability correlating with an increase of temperature and drug concentration in bothcell lines. However, there was no significant difference between sham group and groups of leukemic PMBCstreated by high temperature (44 °C) and bortezomib. In U937 cells, combined treatment by heat shock andbortezomib led to an increase the number of cells underwent the late apoptosis stage. At the same time, similartreatment of PMBCs resulted in the stimulation of early apoptosis. Our data suggest that combination ofbortezomib and hyperthermia enhances apoptosis induction in human cancer white blood cells, indicating atherapeutic potential for blood cancer therapy.

KW - Hyperthermia, cytotoxicity, apoptosis, bortezomib, velcade, blood cancer

M3 - Article

SP - 9

EP - 14

JO - Journal of Thermal Biology

JF - Journal of Thermal Biology

SN - 0306-4565

ER -